BridgeBio Pharma (BBIO) Capital Expenditures Growth (1y) (2019 - 2026)
BridgeBio Pharma (BBIO) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
BridgeBio Pharma |
12.90 Bn |
11.97 Bn |
184.58 Mn |
-79.53% |
| Date | Value |
|---|
| Mar 31, 2026 |
-79.53% |
| Dec 31, 2025 |
2,208.51% |
| Sep 30, 2025 |
-171.32% |
| Mar 31, 2025 |
381.43% |
| Dec 31, 2024 |
-89.20% |
| Sep 30, 2024 |
10.27% |
| Mar 31, 2024 |
483.33% |
| Dec 31, 2023 |
3,446.15% |
| Sep 30, 2023 |
5,792.31% |
| Jun 30, 2023 |
115.14% |
| Mar 31, 2023 |
-98.60% |
| Dec 31, 2022 |
-100.51% |
| Sep 30, 2022 |
-100.20% |
| Jun 30, 2022 |
-134.37% |
| Mar 31, 2022 |
-56.20% |
| Dec 31, 2021 |
159.38% |
| Sep 30, 2021 |
1,077.05% |
| Jun 30, 2021 |
560.98% |
| Mar 31, 2021 |
-56.20% |
| Dec 31, 2020 |
-344.48% |
